Загрузка...
RNF168 facilitates oestrogen receptor ɑ transcription and drives breast cancer proliferation
Oestrogen receptor ɑ (ERɑ) is overexpressed in two‐thirds of all breast cancers and involves in development and breast cancer progression. Although ERɑ‐positive breast cancer could be effective treated by endocrine therapy, the endocrine resistance is still an urgent clinical problem. Thus, further...
Сохранить в:
| Опубликовано в: : | J Cell Mol Med |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6111850/ https://ncbi.nlm.nih.gov/pubmed/29974997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13694 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|